slides · global inventory
Analyze Data
Slide function collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 58,039
Current window 45,541-45,570
Pages 1,935
Rows per page 30
Slide function
45,541-45,570 of 58,039
18
Front | Start Up Pitch Deck | 21 slidesFront | Start Up Pitch Deck | 21 slides · Front
Pitch deck Investor relations 1 hit
04
The chart uses a dual-axis bar chart to represent two different metrics (millions of patients vs billions of medical events) over time.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Need1 hit
05
The chart shows a steady upward trend in PAM, reaching 24.3 billion by Q2 2016.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Need1 hit
06
The slide explains the rationale behind the 2016 revenue guidance revision, balancing positive sales pipeline growth against delayed revenue conversion and market pressure on the CARA platform.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Need1 hit
07
The chart illustrates a shift in revenue seasonality from Q1/Q2 towards Q4 for the 2016 fiscal year.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Need1 hit
19
The chart is a classic waterfall bridge showing the impact of platform mix, price, and efficiency on gross margin.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · VisualizationLoop · Cost Of Inaction1 hit
21
Includes a footnote regarding an undrawn $100 million revolving credit facility.Inovalon | Results Presentation Deck | 22 slides · Inovalon
Conference presentation Investor relations Beat · Visualization1 hit
23
Excludes SBC expense.Shopify | Start Up Pitch Deck | 29 slides · Shopify
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
24
The chart illustrates operating leverage by showing the decline in total operating expenses as a percentage of revenue over time.Shopify | Start Up Pitch Deck | 29 slides · Shopify
Pitch deck Investor relations Beat · Ultimate Achievement1 hit
29
The table shows adjustments for Stock-Based Compensation (SBC) and non-recurring tax expenses.Shopify | Start Up Pitch Deck | 29 slides · Shopify
Pitch deck Investor relations 1 hit
36
The slide includes a disclaimer at the bottom regarding FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
37
The slide references CLSI EP09-A3, a standard for method comparison and bias estimation using patient samples.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
38
The slide includes a disclaimer regarding FDA clearance status.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
39
Includes regression equations, r-squared values, sample sizes, median bias, and Allowable Total Error (ATE) metrics for each lipid type.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
40
The slide includes a disclaimer at the bottom regarding FDA clearance.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
41
The slide uses a table to validate performance against industry-standard benchmarks.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Evidence1 hit
44
References CLSI EP05-A3 standard.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Complication1 hit
45
The slide includes a disclaimer about FDA clearance status and definitions for (L) and (H) samples.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Complication1 hit
47
Includes FDA clearance references and disclaimer.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Complication1 hit
52
References CLSI EP05-A3 standard for precision performance testing.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
53
Includes FDA disclaimer and definitions for (L) and (N) cell counts.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
54
The slide uses a standard table format to define the parameters of a clinical validation study.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
55
The slide presents method comparison data (regression analysis) for three different cell types, including statistical metrics like r-squared, median bias, and Allowable Total Error (ATE).Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
56
The slide shows three scatter plots with regression lines, R-squared values, and performance metrics (bias, ATE, TE).Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
57
Includes technical definitions of error metrics and regulatory disclaimers.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
61
The slide compares the assay's LoD (480 copies/mL) against the CDC Zika test LoD (930 copies/mL).Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
62
n = 3 replicates per test; FDA disclaimer present.Theranos | Investor Conference Presentation Deck | 88 slides · Theranos
Conference presentation Investor relations Beat · Solution1 hit
03
Includes footnotes regarding Asia JV and operating earnings composition.Toys R Us | Results Presentation Deck | 5 slides · Toys R Us
Regulatory filing Investor relations 1 hit
04
The table reconciles operating earnings to Adjusted EBITDA by adding back various expenses and adjustments, further adjusted for intercompany items.Toys R Us | Results Presentation Deck | 5 slides · Toys R Us
Regulatory filing Investor relations 1 hit
05
The table includes specific line items for non-recurring charges like goodwill impairment and store closure costs.Toys R Us | Results Presentation Deck | 5 slides · Toys R Us
Regulatory filing Investor relations 1 hit